litlas
Log inCreate account

Vera Bittner

Active 1993–2025

158
Papers
39,948
Citations
92
h-index
152
i10-index

Citations

Citations per year for Vera Bittner1969: 1 citations1979: 1 citations1983: 1 citations1984: 1 citations1994: 2 citations1995: 14 citations1996: 23 citations1997: 21 citations1998: 33 citations1999: 28 citations2000: 34 citations2001: 45 citations2002: 72 citations2003: 152 citations2004: 152 citations2005: 108 citations2006: 126 citations2007: 163 citations2008: 170 citations2009: 215 citations2010: 204 citations2011: 234 citations2012: 237 citations2013: 308 citations2014: 268 citations2015: 263 citations2016: 300 citations2017: 284 citations2018: 257 citations2019: 1,186 citations2020: 1,232 citations2021: 1,149 citations2022: 994 citations2023: 705 citations2024: 1,200 citations2025: 620 citations2026: 54 citations1970–1978: no citations, so these years are not shown1980–1982: no citations, so these years are not shown1985–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,186 citing papers, 25.8% of this breakdownUnited Kingdom: 1,157 citing papers, 7.1% of this breakdownItaly: 868 citing papers, 5.4% of this breakdownCanada: 836 citing papers, 5.2% of this breakdownChina: 757 citing papers, 4.7% of this breakdownAustralia: 689 citing papers, 4.2% of this breakdownGermany: 614 citing papers, 3.8% of this breakdownNetherlands: 567 citing papers, 3.5% of this breakdownSpain: 426 citing papers, 2.6% of this breakdownFrance: 406 citing papers, 2.5% of this breakdownSwitzerland: 321 citing papers, 2% of this breakdownJapan: 317 citing papers, 2% of this breakdown
0%25.8%Other 31.2%

Institutions

Fields

  • Medicine85.7%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Health Professions1.7%
  • Nursing1.3%
  • Immunology and Microbiology1.1%
  • Neuroscience1%
  • Other3.4%

Topics

  • Lipoproteins and Cardiovascular Health9%
  • Diabetes, Cardiovascular Risks, and Lipoproteins5%
  • Cardiac Health and Mental Health4.1%
  • Cardiovascular and exercise physiology3.1%
  • Cardiac Imaging and Diagnostics2.8%
  • Acute Myocardial Infarction Research2.5%
  • Other73.5%

Coauthors

All papers

Open in search
  1. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    Authors: Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Jay M. Edelberg, Shaun G. Goodman, Corinne Hanotin, Robert A. Harrington, J. Wouter Jukema, Guillaume Lecorps, Kenneth W. Mahaffey, Angèle Moryusef, Robert Pordy, Kirby Quintero, Matthew T. Roe, William J. Sasiela, Jean‐François Tamby, Pierluigi Tricoci, Harvey D. White, Andreas M. Zeiher - New England Journal of Medicine 2018 cited by 3,519

  2. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease

    Authors: Salim S. Virani, L. Kristin Newby, Suzanne V. Arnold, Vera Bittner, LaPrincess C. Brewer, Susan Halli Demeter, Dave L. Dixon, William F. Fearon, Beverly Hess, Heather M. Johnson, Dhruv S. Kazi, Dhaval Kolte, Dharam J. Kumbhani, Jim LoFaso, Dhruv Mahtta, Daniel B. Mark, Margo Minissian, Ann Marie Návar, Amit R. Patel, Mariann R. Piano, Fátima Rodríguez, Amy W. Talbot, Viviany R. Taqueti, Randal J. Thomas, Sean van Diepen, Barbara S. Wiggins, Marlene S. Williams - Journal of the American College of Cardiology 2023 cited by 483

  3. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    Authors: Vera Bittner, Michael Szarek, Philip E. Aylward, Deepak L. Bhatt, Rafael Díaz, Jay M. Edelberg, Zlatko Fras, Shaun G. Goodman, Sigrun Halvorsen, Corinne Hanotin, Robert A. Harrington, J. Wouter Jukema, Virginie Loizeau, Patrick M. Moriarty, Angèle Moryusef, Robert Pordy, Matthew T. Roe, Peter Sinnaeve, Sotirios Tsimikas, Robert A. Vogel, Harvey D. White, Doron Zahger, Andreas M. Zeiher, Philippe Gabríel Steg, Gregory G. Schwartz - Journal of the American College of Cardiology 2020 cited by 572

  4. Exercise Standards for Testing and Training

    Authors: Gerald F. Fletcher, Philip A. Ades, Paul Kligfield, Ross Arena, Gary Balady, Vera Bittner, Lola A. Coke, Jerome L. Fleg, Daniel E. Forman, Thomas C. Gerber, Martha Gulati, Kushal Madan, Jonathan Rhodes, Paul D. Thompson, Mark A. Williams - Circulation 2013 cited by 2,197

  5. Triglycerides and Cardiovascular Disease

    Authors: Michael Miller, Neil J. Stone, Christie M. Ballantyne, Vera Bittner, Michael H Criqui, Henry N. Ginsberg, Anne C. Goldberg, W.J. Howard, Marc S. Jacobson, Penny M. Kris‐Etherton, Terry A. Lennie, Moshe Levi, Theodore Mazzone, Subramanian Pennathur - Circulation 2011 cited by 1,868

  6. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association

    Authors: Laxmi S. Mehta, Karol E. Watson, Ana Barac, Theresa M. Beckie, Vera Bittner, Salvador Cruz‐Flores, Susan Dent, Lavanya Kondapalli, Bonnie Ky, Tochukwu Okwuosa, Ileana L. Piña, Annabelle Santos Volgman - Circulation 2018 cited by 827

  7. Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association

    Authors: Connie White‐Williams, Laura Rossi, Vera Bittner, Andrea Driscoll, Raegan W. Durant, Bradi B. Granger, Lucinda J. Graven, Lisa Kitko, Kim Newlin, Maria R. Shirey - Circulation 2020 cited by 336

  8. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    Authors: Kausik K Ray, Helen M Colhoun, Michael Szarek, Marie T. Baccara‐Dinet, Deepak L. Bhatt, Vera Bittner, Andrzej Budaj, Rafael Díaz, Shaun G Goodman, Corinne Hanotin, Robert A Harrington, J. Wouter Jukema, Virginie Loizeau, Renato D. Lópes, Angèle Moryusef, Jan Murin, Robert Pordy, Arsen Ristić, Matthew T. Roe, José Tuñón, Harvey D. White, Andreas M. Zeiher, Gregory G. Schwartz, Philippe Gabríel Steg, Gregory G. Schwartz, Philippe Gabríel Steg, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Shaun G. Goodman, Robert A. Harrington, J. Wouter Jukema, Michael Szarek, Harvey D. White, Andreas M. Zeiher, Pierluigi Tricoci, Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina Gotcheva, Juan Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Željko Reiner, Petr Ostadal, Margus Viigimaa, Markku S. Nieminen, Vakhtang Chumburidze, Nikolaus Marx, Nicolas Danchin, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, K. Yusoff, Gabriel Arturo Ramos López, Marco Alings, Sigrun Halvorsen, Roger M. Correa Flores, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H Asita de Silva, Emil Hagström, Ulf Landmesser, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Robert A. Vogel and 1,603 more - The Lancet Diabetes & Endocrinology 2019 cited by 328

  9. Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome

    Authors: Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek, Vera Bittner, Rafael Díaz, Shaun G. Goodman, Yong-Un Kim, J. Wouter Jukema, Robert Pordy, Matthew T. Roe, Harvey D. White, Deepak L. Bhatt - Circulation 2020 cited by 187

  10. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

    Authors: Emil Hagström, Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Nicolas Danchin, Rafael Díaz, Shaun G. Goodman, Robert A. Harrington, J. Wouter Jukema, Evangelos Liberopoulos, Nikolaus Marx, Jennifer McGinniss, Garen Manvelian, Robert Pordy, Michel Scemama, Harvey D. White, Andreas M. Zeiher, Gregory G. Schwartz, Gregory G. Schwartz, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Shaun G. Goodman, Robert A. Harrington, J. Wouter Jukema, Michael Szarek, Harvey D. White, Andreas M. Zeiher, Pierluigi Tricoci, Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Díaz, Philip E Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina N Gotcheva, Shaun G. Goodman, Juan Carlos Prieto, Huo Yong, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ostadal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos, Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo-Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M Correa Flores, Rody G. Sy, Andrzej Budaj, João Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Ján Murín, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty and 1,635 more - Circulation 2022 cited by 122

  11. Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: 2007 Update

    Authors: Gary Balady, Mark A. Williams, Philip A. Ades, Vera Bittner, Patricia Comoss, Jo Anne Micale Foody, Barry A. Franklin, Bonnie Sanderson, Douglas R. Southard - Circulation 2007 cited by 1,123

  12. Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

    Authors: Michael Szarek, Vera Bittner, Philip E. Aylward, Marie T. Baccara‐Dinet, Deepak L. Bhatt, Rafael Díaz, Zlatko Fras, Shaun G. Goodman, Sigrun Halvorsen, Robert A. Harrington, J. Wouter Jukema, Patrick M. Moriarty, Robert Pordy, Kausik K. Ray, Peter Sinnaeve, Sotirios Tsimikas, Robert A. Vogel, Harvey D. White, Doron Zahger, Andreas M. Zeiher, Philippe Gabríel Steg, Gregory G. Schwartz, for the ODYSSEY OUTCOMES Investigators - European Heart Journal 2020 cited by 209

  13. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome

    Authors: J. Wouter Jukema, Michael Szarek, Laurien E. Zijlstra, H Asita de Silva, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Jay M. Edelberg, Shaun G. Goodman, Corinne Hanotin, Robert A. Harrington, Yuri Karpov, Angèle Moryusef, Robert Pordy, Juan Carlos Prieto, Matthew T. Roe, Harvey D. White, Andreas M. Zeiher, Gregory G. Schwartz, Philippe Gabríel Steg - Journal of the American College of Cardiology 2019 cited by 237

  14. Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States

    Authors: Sanne A. E. Peters, Lisandro D. Colantonio, Hong Zhao, Vera Bittner, Yuling Dai, Michael E. Farkouh, Keri L. Monda, Monika M. Safford, Paul Muntner, Mark Woodward - Journal of the American College of Cardiology 2018 cited by 173

  15. Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests

    Authors: Michael Szarek, Esther Reijnders, J. Wouter Jukema, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Sergio Fazio, Geneviève Garon, Shaun G. Goodman, Robert A. Harrington, L. Renee Ruhaak, Markus Schwertfeger, Sotirios Tsimikas, Harvey D. White, Philippe Gabríel Steg, Christa M. Cobbaert, Gregory G. Schwartz, for the ODYSSEY OUTCOMES Investigators - Circulation 2023 cited by 59

  16. Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study

    Authors: C. Noel Bairey Merz, Leslee J. Shaw, Steven E. Reís, Vera Bittner, Sheryl F. Kelsey, Marian B. Olson, B. Delia Johnson, Carl J. Pepine, Sunil Mankad, Barry L. Sharaf, William J. Rogers, Gerald M. Pohost, Amir Lerman, Arshed A. Quyyumi, George Sopko - Journal of the American College of Cardiology 2006 cited by 854

  17. Referral, Enrollment, and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical Centers and Beyond

    Authors: Gary Balady, Philip A. Ades, Vera Bittner, Barry A. Franklin, Neil F. Gordon, Randal J. Thomas, Gordon F. Tomaselli, Clyde W. Yancy - Circulation 2011 cited by 618

  18. Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy

    Authors: Deborah Grady, David Herrington, Vera Bittner, Roger S. Blumenthal, Michael Davidson, Mark A. Hlatky, Judith Hsia, Stephen B. Hulley, Alan Herd, Steven S. Khan, L. Kristin Newby, David D. Waters, Eric Vittinghoff, Nanette K. Wenger - JAMA 2002 cited by 1,935

  19. Resistance Exercise in Individuals With and Without Cardiovascular Disease: 2007 Update

    Authors: Mark A. Williams, William L. Haskell, Philip A. Ades, Ezra A. Amsterdam, Vera Bittner, Barry A. Franklin, Meg Gulanick, Susan T. Laing, Kerry J. Stewart - Circulation 2007 cited by 1,214

  20. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction

    Authors: Maria-Corina Șerban, Lisandro D. Colantonio, Angelika D. Manthripragada, Keri L. Monda, Vera Bittner, Maciej Banach, Ligong Chen, Lei Huang, Ricardo Dent, Shia T. Kent, Paul Muntner, Robert S. Rosenson - Journal of the American College of Cardiology 2017 cited by 317

  21. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association

    Authors: Daniel Soffer, Nicholas Marston, Kevin C. Maki, Terry A. Jacobson, Vera Bittner, Jessica M. Peña, George Thanassoulis, Seth S. Martin, Carol F. Kirkpatrick, Salim S. Virani, Dave L. Dixon, Christie M. Ballantyne, Alan T. Remaley - Journal of clinical lipidology 2024 cited by 77

  22. Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women

    Authors: Ahmed AlBadri, C. Noel Bairey Merz, B. Delia Johnson, Janet Wei, Puja K. Mehta, Galen Cook‐Wiens, Steven E. Reís, Sheryl F. Kelsey, Vera Bittner, George Sopko, Leslee J. Shaw, Carl J. Pepine, Bina Ahmed - Journal of the American College of Cardiology 2019 cited by 210

  23. Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

    Authors: Gregory G. Schwartz, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Maja Bujas‐Bobanovic, Rafael Díaz, Sergio Fazio, Zlatko Fras, Shaun G. Goodman, Robert A. Harrington, J. Wouter Jukema, Garen Manvelian, Robert Pordy, Kausik K. Ray, Michel Scemama, Harvey D. White, Philippe Gabríel Steg, for the ODYSSEY OUTCOMES Investigators - European Heart Journal 2023 cited by 46

  24. HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

    Authors: Philip J. Barter, Antonio M. Gotto, John C. LaRosa, Jaman Maroni, Michael Szarek, Scott M. Grundy, John J.P. Kastelein, Vera Bittner, Jean‐Charles Fruchart - New England Journal of Medicine 2007 cited by 1,618